Cannara Biotech Inc. announced the receipt of its cultivation licence from Health Canada for Phase 1 of its purpose-built Farnham Facility, in Québec. Cultivation is expected to begin immediately with a first harvest to take place in the second quarter of 2020; the granted cultivation and processing licences are for Phase 1 of the Farnham Facility (170,000 sq. ft.). The licenced area is part of a larger 625,000 sq. ft. multipurpose and modern facility; Phase 1 includes a designated space for extraction and processing; Creation of 100 local jobs; and annual cultivation capacity is estimated at up to 20,000 kg per year.